Pion
www.pion-inc.com
  • Status Current Investment
  • Location Billerica, MA
  • Industry Industrial and Life Sciences Technology
  • Investment Date May 2021
About

Pion is a leading provider of analytical instrumentation for formulation development and quality control in the life sciences industry.

Value proposition

Helps pharmaceutical scientists to make efficient, early phase screening of drug compounds and provide critical data for the development of drugs. 

Customers

Leading biopharmaceutical, academic, and research institutions around the globe. Its products are used in labs focused on drug screening and development of formulations across small molecule drugs, large molecule biologics, vaccines, and other therapeutics.

Related News
Dec 22 2022
Pion Acquires BEE International
Dec 12 2022
Pion Inc acquires Two Square Science adding new capabilities to an innovative portfolio for drug development
Sep 29 2022
Pion Showcases How to Achieve In-Vivo Level Insights Via In-Vitro Solutions at AAPS PharmSci 360 2022
Jun 29 2022
Pion’s commercial offering goes global with two key appointments
Mar 25 2022
Pion Boosts Service Offering, Bringing Excellent Customer Experiences to the Fore
Nov 16 2021
Pion Inc Unveils New Model of its Industry-First Subcutaneous Injection Site Simulator Investigate Drug Release Performance of Subcutaneous Formulations In Vitro, With New SCISSOR N3
May 20 2021
SFW Capital Partners Completes A Strategic Recapitalization of Pion Inc., a Leading Instrumentation Provider for Life Sciences

This Website contains links to third-party websites. These links are provided solely as a convenience to you and does not imply an affiliation, sponsorship, endorsement, approval, investigation, verification, or monitoring by SFW of the contents on such third-party websites. SFW is not responsible for the content of any website owned by a third party that may be linked to this Website regardless of whether the link is provided by SFW or a third party. SFW does not prepare or maintain, has not and will not review or update, and does not guarantee the accuracy, timeliness, completeness, suitability, reliability, or usefulness of any information contained on a linked third-party website. If you decide to access linked third-party websites, you do so at your own risk.

The investments in IAG Research, Mettler Toledo, Telephia, and Waters were led by members of SFW management prior to the formation of SFW in an unrelated entity in which the members of SFW management were principals